Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
Elite Laboratories, Inc. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 10/12/2022
- Package NDC
- 64850-504-01
- Generic name
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet
- Contact info
- 888-852-6657
- Availability
- Available
- Update date
- 09/16/2026
- Dosage form
- Tablet
- Company name
- Elite Laboratories, Inc.
- Status
- Current
- Presentation
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA211352
- Brand name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Generic name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
- Manufacturer name
- Elite Laboratories, Inc.
- Product NDC
- 64850-504, 64850-500, 64850-501, 64850-502, 64850-503, 64850-505, 64850-506
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE
- RxCUI
- 541363, 541878, 541892, 577957, 577961, 687043, 1009145
- SPL ID
- a41cf8e5-cb1b-488c-96b3-3bef8283d6c4
- SPL set ID
- e677690f-790f-4626-ad78-097cdb6ea540
- Package NDC
- 64850-500-01, 64850-500-05, 64850-500-30, 64850-501-01, 64850-501-05, 64850-501-30, 64850-502-01, 64850-502-05, 64850-502-30, 64850-503-01, 64850-503-05, 64850-503-30, 64850-504-01, 64850-504-05, 64850-504-30, 64850-505-01, 64850-505-05, 64850-505-30, 64850-506-01, 64850-506-05, 64850-506-30
- UNII
- 6DPV8NK46S, G83415V073, O1ZPV620O4, JJ768O327N